Tonight will be mainly clear. There will be a few patches of cloud moving in from the east with the chance of the odd shower, wintry on the hills. A breezy and colder night. Wednesday Tomorrow ...

Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...

GSK's latecomer to the PD-1/PD-L1 inhibitor category Jemperli has barely started to bring in revenues, and is a world away from the company's hopes of blockbuster revenues by 2031. The drugmaker ...